Merck Gets China Nod on HPV Shot for Men

Merck's HPV vaccine gets China approval for men amid declining sales
Merck's human papillomavirus vaccine has been approved for men in China, it said on Wednesday, providing the U.S. drugmaker a much-needed boost in a key market where demand has been falling among women.
Merck Gets China Nod on HPV Shot for Men Amid Sales Slump
China’s drug regulator approved Merck & Co.’s blockbuster HPV vaccine for use by men, opening a new untapped market for the US drug giant after a rush among women to get the shot lost steam.
MSD’s HPV vaccine gains China NMPA’s expanded approval for males
China's National Medical Products Administration has granted expanded approval to MSD's GARDASIL for use in males aged nine to 26 years.
Merck says HPV vaccine for men approved by China's drug regulator
U.S. drugmaker Merck & Co said on Wednesday its human papillomavirus (HPV) vaccine for men has been approved by China's medical products administration, providing a much-needed boost to the company in a key market.
Gardasil Gains Ground: Merck's HPV Vaccine for Men Approved in China
Merck's Gardasil vaccine, previously only available to women, has now been approved for men in China. This approval may help Merck overcome declining sales due to weak demand among women and disruptions caused by China's anti-corruption campaign.
HPV vaccine for males approved in China
US pharmaceutical company Merck & Co said on Wednesday that its four-valent human papillomavirus vaccine has been approved for men aged 9 to 26 by China's top drug regulator.
Merck’s GARDASIL® Receives Expanded Approval for Males in China
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the National Medical Products Administration (NMPA) of China approved GARDASIL ® [Human Papillomavirus Quadrivalent (Types 6,
Merck's HPV Vaccine Gains Ground in China
U.S. drugmaker Merck & Co has received approval in China for its HPV vaccine's use in males, expanding its market reach despite earlier weak sales in the region. This move marks a potential growth opportunity as Gardasil has been key to Merck's market strategy alongside cancer treatment Keytruda.
cidrap.umn1d
Bundling may boost HPV vaccine uptake, study finds
Human papillomavirus vaccination (HPV) rates are at suboptimal levels across the United States, but a new study published in ...
Onlymyhealth4d
What is the Recommended Age for Receiving the HPV Vaccine? Is It Effective For Adults Over 26?
The human papillomavirus HPV vaccine is one of the most important vaccine that one should get injected Read ahead to know ...
manilastandard5h
Batangas LGU ramps up HPV vaccination drive to fight cervical cancer
The Sto. Tomas local government has launched a targeted HPV vaccination program to combat cervical cancer among young girls.
Cervical Cancer and HPV: 6 essential facts you need to know
To observe Cervical Cancer Awareness Month 2025, let us know about the link between cervical cancer and HPV. In the articles, ...
Merck says its HPV vaccine for men was approved by China's drug regulator
U.S. drugmaker Merck & Co said on Wednesday its human papillomavirus (HPV) vaccine for men has been approved by China's ...
The Nassau Guardian1d
HPV isn't just a woman's issue: What men need to know
Human Papillomavirus (HPV) is a widespread sexually transmitted infection, affecting nearly 80 percent of sexually active ...
The elimination of cervical cancer in NZ is within reach—but not without funding and a plan
After committing to a global plan to eliminate cervical cancer, New Zealand is lagging behind Australia and other countries ...
thehealthy3d
Over 30? This Cancer Screening Should Now Be “Standard” for You, Say Expert Doctors
It looks for a common diagnosis that's associated with close to 10 cancer types. Here are the guidelines national experts are ...